A. Babić

ORCID: 0000-0002-1444-5604 · 3 papers in corpus
supplementary-materials 2023
Supplementary Table S1, Table S2, Table S3, Table S4, Table S5 from Common Analgesic Use for Menstrual Pain and Ovarian Cancer Risk
·doi:10.1158/1940-6207.22534316

Supplementary Table S1 shows characteristics among ovarian cancer cases, Supplementary Table S2 shows the association between duration of analgesic use and ovarian cancer risk, Supplementary Table S3 shows the association between frequency …

supplementary-materials 2023
Supplementary Table S1, Table S2, Table S3, Table S4, Table S5 from Common Analgesic Use for Menstrual Pain and Ovarian Cancer Risk
·doi:10.1158/1940-6207.22534316.v1

Supplementary Table S1 shows characteristics among ovarian cancer cases, Supplementary Table S2 shows the association between duration of analgesic use and ovarian cancer risk, Supplementary Table S3 shows the association between frequency …

article 2018
Abstract 2205: Prediction model of CA125 among premenopausal women
·doi:10.1158/1538-7445.am2018-2205

Abstract Background: Cancer antigen 125 (CA125) is a membrane-bound glycosylated mucin that has been reported to be the most promising biomarker for ovarian cancer screening, although results from two large randomized trials comparing scree…